Check If I May Qualify

Medicare Diabetic Supplies

How Medicare Covers Your Diabetic Equipment

Medicare Part B covers a broad range of diabetic supplies as durable medical equipment, including continuous glucose monitors, blood glucose meters, test strips, lancets, and insulin pump supplies. Coverage is available under Original Medicare and, with some plan-specific variation, under Medicare Advantage as well. This page walks through what’s covered, what you can expect to pay in 2026, and the specific eligibility rules that apply to Medicare beneficiaries.

What Medicare Part B Covers

Continuous glucose monitors

Medicare covers therapeutic CGMs, including the Dexcom G7 and FreeStyle Libre 3, for beneficiaries who use insulin of any kind or who have a documented history of problematic hypoglycemia. Coverage requires a valid prescription, confirmation that you or a caregiver have been trained to use the device, and a visit with your treating provider roughly every six months to confirm ongoing medical necessity.

Blood glucose meters

Standard fingerstick meters, including brands like Accu-Chek, OneTouch, Contour Next, and True Metrix, are covered for diagnosed diabetic beneficiaries with a valid prescription.

Test strips and lancets

Medicare’s standard allowance is up to 300 test strips and 300 lancets every three months for beneficiaries who use insulin, and up to 100 of each every three months for beneficiaries who don’t use insulin. Higher quantities are available when your doctor documents medical necessity for more frequent testing.

Insulin pump supplies

For traditional, tubed external insulin pumps, Medicare covers the pump along with infusion sets, reservoirs, and the insulin used specifically with the pump under the Part B durable medical equipment benefit, provided medical necessity is documented. Tubeless, disposable patch pumps are typically handled under Part D instead, following that plan’s drug formulary rather than the DME benefit.

Diabetes screening and self-management training

Beyond supplies, Medicare covers up to two diabetes screening tests every twelve months for beneficiaries at risk, and up to ten hours of diabetes self-management training, split between one hour of individual instruction and nine hours of group instruction, with up to two additional hours of follow-up training available in later years.

What You’ll Pay in 2026

Original Medicare Part B has a standard monthly premium of $202.90 in 2026, an increase from $185.00 in 2025, and an annual deductible of $283, up from $257 the previous year. Once you’ve met this annual deductible, Medicare typically covers 80% of the Medicare-approved amount for covered diabetic DME, with you responsible for the remaining 20% coinsurance, unless you have supplemental coverage, such as a Medigap plan, that covers some or all of that difference.

These figures apply to Original Medicare specifically. If you’re enrolled in a Medicare Advantage plan instead, your specific premium, deductible, and cost-sharing structure is set by your plan rather than following these standard Original Medicare figures, though your plan is required to cover the same core diabetic DME benefits.

Medicare Advantage Considerations

Medicare Advantage plans, sometimes called Part C, combine Part A, Part B, and typically Part D coverage into a single private insurance plan. These plans must cover the same core diabetic DME benefits as Original Medicare, but the details often differ in meaningful ways:

Preferred brand lists

Many Medicare Advantage plans maintain a list of preferred meter and test strip brands that carry the lowest cost-sharing tier, and these lists can change from year to year. A brand you’ve used for years can lose preferred status, sometimes with little advance notice, which is why we confirm your plan’s current preferred list during every verification rather than assuming last year’s information still applies.

Prior authorization

Medicare Advantage plans frequently require prior authorization for CGMs and insulin pumps, sometimes with documentation standards that go beyond what Original Medicare requires for the same equipment.

Network requirements

Your plan may require using a specific in-network supplier, separate from Original Medicare’s general CMS-enrollment requirement, so confirming network status is part of our standard verification process for Medicare Advantage beneficiaries.

Dual Eligibility: Medicare and Medicaid Together

If you qualify for both Medicare and Medicaid, known as dual eligibility, Medicare generally pays first for covered diabetic supplies, with Medicaid potentially covering some or all of your remaining 20% coinsurance, depending on your specific state’s Medicaid program and your eligibility category. Our team coordinates verification across both programs for dually eligible patients, confirming exactly how the two work together for your specific supply needs rather than leaving you to interpret two separate sets of coverage rules.

Keeping Your CGM and Pump Coverage Active

Medicare treats CGM and insulin pump coverage as an ongoing benefit rather than a one-time approval. Roughly every six months, your treating provider needs to confirm, through a visit, that your device remains medically necessary and that you’re actively using the data it provides to manage your treatment. Missing this window is a common, avoidable reason a refill gets denied. Our patient support team tracks these renewal dates on your account and can help coordinate the visit with your doctor’s office before the deadline arrives.

Getting Started

If you’re a Medicare beneficiary and want to know exactly what your specific plan, whether Original Medicare or a Medicare Advantage plan, covers for your diabetic supplies, a free eligibility check gives you a clear answer along with your expected out-of-pocket cost before anything ships.

Check My Medicare Eligibility
Call 1-800-XXX-XXXX

Frequently Asked Questions

Yes, Medicare Part B covers both for beneficiaries who use insulin or have a documented history of problematic hypoglycemia, along with a valid prescription and required documentation.

The 2026 Part B deductible is $283, up from $257 in 2025. Once you’ve met this deductible, Medicare typically covers 80% of the approved amount for diabetic DME, with you responsible for the remaining 20%.

Up to 300 of each every three months for insulin users, and up to 100 of each every three months for non-insulin users, with higher quantities available if your doctor documents medical necessity for more frequent testing.

They’re required to cover the same core benefits, but specific rules around preferred brands, prior authorization, and network requirements often differ from Original Medicare and vary by plan.

As a dually eligible beneficiary, Medicare typically pays first, and Medicaid may cover some or all of your remaining coinsurance depending on your state’s program. We coordinate verification across both for you.

Roughly every six months, to confirm the device remains medically necessary and that you’re using it as part of an active treatment plan.

Medicare coverage details, including premiums and deductibles, reflect 2026 figures and are subject to change. Actual coverage depends on your specific plan, whether Original Medicare or Medicare Advantage, and your documented medical necessity. This page provides general information and is not a guarantee of coverage.